Conneqt Health Limited · ASX:CQT
Conneqt Health — Investor Presentation (July 2026)
21 slides from Conneqt Health's investor presentation, Jul 22, 2026
Slide 1: CONNEQT Health Investor Update Q4 2026
For personal use only CONNEQT Health Investor Update | Q4, 2026
Slide 2: Four Numbers From the Quarter
THE QUARTER AT A GLANCE Four Numbers From the Quarter Recurring revenue and enterprise adoption both grew over the June quarter. For personal use only CONSUMER DIGITAL ENTERPRISE ENTERPRISE $1.3M +71% $94K 7 Consumer revenue Digital growth Cumulative clinical New clinical subscription (Care+ in-app
Slide 3: Consumer: Record Revenue Achieved US$1M of Cash Receipts
QUARTER HIGHLIGHTS Consumer: Record Revenue Achieved US$1M of Cash Receipts Continued momentum driven by Pulse adoption, digital expansion, and strategic partnerships. For personal use only 12,000+ Pulse devices deployed 3,574 Pulse devices sold $1.3M +33% QoQ A $1.1M +21% 34% on a A$68K constant Di
Slide 4: Enterprise: Building a Recurring Revenue Platform
QUARTER HIGHLIGHTS Enterprise: Building a Recurring Revenue Platform Contracted ARR and TCV increased 70% and 65% QoQ, validating the subscription-first strategy. For personal use only $163.8K 7 new +65% Clinical subscription agreements this quarter $38.8K new ARR added $99.3K $94.2K $64.5K +70% Tot
Slide 5: Group: Another Quarter of Strong Execution
GROUP Group: Another Quarter of Strong Execution Consumer momentum, research stability and enterprise progress drove another quarter of growth. For personal use only $2.0M $2.1M $2.1M Q4 Group revenue +7% QoQ $10M Annualised run-rate of Group revenue and other income Driven by Pulse and research gro
Slide 6: Q4 FY26 Commercial Highlights
COMMERCIAL Q4 FY26 Commercial Highlights Total Clinical Subscription Base CONNEQT Pulse Partnerships For personal use only 11 advanced testing locations Expanding arterial health assessments across a 70- location franchise network. CONNEQT Pulse to CONNEQT Pulse Continued progress be featured in an
Slide 7: Progress Against Last Quarter's Commitments
QUARTERLY SCORECARD Progress Against Last Quarter's Commitments The priorities set out in the Q3 FY26 update, and where each now stands. For personal use only WH AT WE TO LD YO U LAST Q UAR TE R WH E R E IT STAN DS N O W Consumer revenue +21% QoQ (34% on a Sustain strong double-digit quarterly Pulse
Slide 8: Progress Against Last Quarter's Commitments
QUARTERLY SCORECARD Progress Against Last Quarter's Commitments The priorities set out in the Q3 FY26 update, and where each now stands. For personal use only WH AT WE TO LD YO U LAST Q UAR TE R WH E R E IT STAN DS N O W Launch arterial health analytics services SphygmoCloud advancing; FDA Pre-Submi
Slide 9: Priorities for FY27
For personal use only Priorities for FY27
Slide 10: We're Transitioning Across Three Axes Simultaneously
We’re Transitioning Across Three Axes Simultaneously For personal use only Hardware → Cloud Platform Transactional → Recurring Single Device → Ecosystem Revenue Value-Add Value-Add Value-Add Shifts value creation from hardware Expands lifetime customer value Positions CQT as the platform for to soft
Slide 11: Priorities for the Year Ahead: Platform & Technology
FY27 ROADMAP Priorities for the Year Ahead Directional priorities across the year For personal use only Platform & Technology H1 FY27 · now underway H2 FY27 · scaling Exiting FY27 · platform Transition device-led → SaaS & data Advance SphygmoCloud & FDA Build the Biomarker-as-a-Service platform; Sph
Slide 12: Priorities for the Year Ahead: Enterprise
FY27 ROADMAP Priorities for the Year Ahead Directional priorities across the year For personal use only Enterprise H1 FY27 · now underway H2 FY27 · scaling Exiting FY27 · platform Expand analytics to pharma & Accelerate advanced-testing, Reference-led growth across multi- clinical-trial partners; sc
Slide 13: Priorities for the Year Ahead: Consumer
FY27 ROADMAP Priorities for the Year Ahead Directional priorities across the year For personal use only Consumer H1 FY27 · now underway H2 FY27 · scaling Exiting FY27 · platform Launch CONNEQT App v2 — Expand installed base; grow Arterial Age, telehealth, premium Pulse V.2 (OTC) expansion premium su
Slide 14: How It Comes Together
How It Comes Together CONNEQT Pulse Legacy, doesn’t speak cloud and we are exploring how to do so w/o triggering regulatory review. SphygmoCor® Cloud SphygmoCor XCEL For personal use only Pulse + all future devices Analytics store data in the Data Lake Data Lake CONNEQT V2 XCEL V2 Algorithm V2+ will
Slide 15: We are building the market from both directions
T H E C O M P A N Y - B U I L D I N G T H E S I S We are building the market from both directions From the customer upward — consumers and clinicians paying today for arterial health insight. From the system downward — the evidence, economics and policy for population scale. For personal use only S
Slide 16: Heart attacks cost the US $85B/yr, what if we screened for its risk?
CARDIOVASCULAR DISEASE REMAINS ONE OF THE MOST EXPENSIVE HEALTH BURDENS Heart attacks cost the US $85B/yr, what if we screened for its risk? For personal use only Mammograms before breast cancer 1/3 of patients are under 65 symptoms Colonoscopies before colorectal cancer develops Arterial health ass
Slide 17: We are not waiting for this market — we already building it
BUI LDI NG FROM BOTTOM UP AND TOP DOWN We are not waiting for this market — we already building it For personal use only S Y S T E M D O W N — T H E C A S E F O R S C R E E N I N G US$85B problem Prevention is accessible Evidence & policy Heart-attack burden, 65% of it A 1% reduction funds screening
Slide 18: Corporate
For personal use only Corporate
Slide 19: Oversubscribed Placement, Now Fully Funded
Oversubscribed Placement, Now Fully Funded Strong Support from Regal Funds Management, high net worth shareholders and the Board. Oversubscribed by $2.0 Million Capital Raised Bookbuild Breakdown For personal use only 5% An additional $2.0 million funds raised, the placement was Tranche Two launched
Slide 20: Share Purchase Plan
Share Purchase Plan ASX:CQT Eligible shareholders can apply for up to How to participate A$30,000 in new CQT shares Action required before close For personal use only A limited-time opportunity to participate in CONNEQT’s next phase of growth — with the SPP currently expected to close on Friday, 24
Slide 21: For personal use only
CONNE QT. Health Ajuo asn seuossead JO04